Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Mar'17
Net Sales
30,598.82
24,961.50
17,745.04
10,767.02
5,954.33
2,878.22
547.81
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
30,598.82
24,961.50
17,745.04
10,767.02
5,954.33
2,878.22
547.81
Raw Material Cost
24,080.34
19,978.34
13,608.79
9,495.68
5,067.30
2,508.15
410.05
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
1,372.91
1,547.61
1,038.36
737.41
643.45
381.24
289.06
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.67
4.63
2.80
24.64
32.68
11.93
7.94
Selling and Distribution Expenses
5,795.10
5,426.88
3,577.02
1,048.73
743.46
381.21
245.38
Other Expenses
-60.46
-66.81
-55.67
-47.84
-42.02
-24.44
-17.18
Total Expenditure (Excl Depreciation)
30,650.41
26,289.32
17,670.23
10,828.10
6,066.68
3,038.09
780.63
Operating Profit (PBDIT) excl Other Income
-51.6
-1327.8
74.80000000000001
-61.1
-112.30000000000001
-159.9
-232.8
Other Income
643.34
889.81
385.03
164.74
44.55
69.78
2.47
Operating Profit (PBDIT)
664.59
-364.52
481.20
136.54
-64.41
-87.56
-225.02
Interest
6.67
4.63
2.80
24.64
32.68
11.93
7.94
Exceptional Items
31.88
191.66
62.13
-24.69
30.67
-7.31
-0.52
Gross Profit (PBDT)
6,518.48
4,983.17
4,136.25
1,271.34
887.03
370.07
137.77
Depreciation
72.85
73.48
37.82
38.82
4.66
5.31
5.33
Profit Before Tax
616.95
-250.97
502.71
48.39
-71.08
-112.11
-238.81
Tax
19.13
16.29
66.94
27.81
36.15
16.37
1.79
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
609.86
-322.13
398.60
-7.39
-95.75
-126.05
-239.41
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
609.86
-322.13
398.60
-7.39
-95.75
-126.05
-239.41
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.98
-0.47
-6.76
-10.22
-11.47
-2.43
-1.18
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
610.84
-322.60
391.85
-17.61
-107.22
-128.48
-240.60
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
17,333.45
17,406.37
16,962.59
5,757.80
3,264.31
3,218.62
1,328.18
Earnings per share (EPS)
0.04
-0.02
0.03
-0.0
-0.01
-0.01
-0.03
Diluted Earnings per share
0.04
-0.02
0.03
-0.0
-0.01
-0.01
-0.03
Operating Profit Margin (Excl OI)
-0.17%
-5.32%
0.33%
-0.62%
-1.91%
-5.65%
-42.5%
Gross Profit Margin
2.25%
-0.71%
3.05%
0.81%
-1.12%
-3.71%
-42.62%
PAT Margin
1.99%
-1.29%
2.25%
-0.07%
-1.61%
-4.38%
-43.7%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2023 is 22.58% vs 40.67% in Mar 2022
Consolidate Net Profit
YoY Growth in year ended Mar 2023 is 289.34% vs -182.34% in Mar 2022
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2023 is 101.70% vs -1,403.85% in Mar 2022
Interest
YoY Growth in year ended Mar 2023 is 45.65% vs 64.29% in Mar 2022
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2023 has improved from Mar 2022
Compare Annual Results Of Alibaba Health Information Technology Ltd. With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
30,598.82
1,37,585.84
-1,06,987.02
-77.76%
Other Operating Income
0.00
0.00
0.00
Total Operating income
30,598.82
1,37,585.84
-1,06,987.02
-77.76%
Raw Material Cost
24,080.34
62,855.71
-38,775.37
-61.69%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
1,372.91
18,753.82
-17,380.91
-92.68%
Power Cost
0
0
0.00
Manufacturing Expenses
6.67
905.33
-898.66
-99.26%
Selling and Distribution Expenses
5,795.10
47,601.76
-41,806.66
-87.83%
Other Expenses
-60.46
-670.38
609.92
90.98%
Total Expenditure (Excl Depreciation)
30,650.41
1,23,412.86
-92,762.45
-75.16%
Operating Profit (PBDIT) excl Other Income
-51.60
14,172.97
-14,224.57
-100.36%
Other Income
643.34
1,736.93
-1,093.59
-62.96%
Operating Profit (PBDIT)
664.59
23,651.26
-22,986.67
-97.19%
Interest
6.67
905.33
-898.66
-99.26%
Exceptional Items
31.88
1,825.83
-1,793.95
-98.25%
Gross Profit (PBDT)
6,518.48
74,730.13
-68,211.65
-91.28%
Depreciation
72.85
7,741.36
-7,668.51
-99.06%
Profit Before Tax
616.95
16,830.41
-16,213.46
-96.33%
Tax
19.13
162.63
-143.50
-88.24%
Provisions and contingencies
0.00
0
0.00
Profit After Tax
609.86
16,626.57
-16,016.71
-96.33%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
609.86
16,626.57
-16,016.71
-96.33%
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.98
9.76
-8.78
-89.96%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
610.84
16,636.33
-16,025.49
-96.33%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
17,333.45
65,985.41
-48,651.96
-73.73%
Earnings per share (EPS)
0.04
3.77
-3.73
-98.94%
Diluted Earnings per share
0.04
3.77
-3.73
-98.94%
Operating Profit Margin (Excl OI)
-0.17%
10.30%
0.00
-10.47%
Gross Profit Margin
2.25%
17.86%
0.00
-15.61%
PAT Margin
1.99%
12.08%
0.00
-10.09%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 3,059.88 Million
in Mar 2023Figures in Million
YoY Growth in year ended Mar 2023 is 22.58% vs 40.67% in Mar 2022
Annual - Consolidate Net Profit
Consolidate Net Profit 61.08 Million
in Mar 2023Figures in Million
YoY Growth in year ended Mar 2023 is 289.34% vs -182.34% in Mar 2022
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.13 Million
in Mar 2023Figures in Million
YoY Growth in year ended Mar 2023 is 101.70% vs -1,403.85% in Mar 2022
Annual - Interest
Interest 0.67 Million
in Mar 2023Figures in Million
YoY Growth in year ended Mar 2023 is 45.65% vs 64.29% in Mar 2022
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -0.17%
in Mar 2023Figures in %
YoY Growth in year ended Mar 2023 has improved from Mar 2022






